SL1002 clinical trials
Also written SL-1002.
How each study uses SL1002 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- SL-1002
- 3
Studies by the year they started
3 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2022 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Saol Therapeutics Inc (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test SL1002, phase 3 first.
- Nov 2026Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee PainPhase 3 · Saol Therapeutics Inc
Studies
Open first, then newest update. How each study uses SL1002 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee PainActive, not recruitingPhase 3Saol Therapeutics IncNCT07226258Written as SL1002
- Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb SpasticityActive, not recruitingPhase 2Saol Therapeutics IncNCT05311215Written as SL-1002
- Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee PainActive, not recruitingPhase 2Saol Therapeutics IncNCT05470608Written as SL-1002